EBITDA for McKesson (MCK)
According to McKesson's latest reported financial statements, the company's current EBITDA (TTM) is $6.47B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
MCK
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$6.47B
YoY change
+12.5%
5Y CAGR
+17.8%
Peak year (2017)
$8.11B
Cumulative EBITDA
$63.12B
EBITDA history chart for McKesson (MCK) from 1995 to 2025
EBITDA history table for McKesson (MCK) from 1995 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $5.25B | +12.5% | ||
| 2024 | $4.67B | -18.6% | ||
| 2023 | $5.74B | +84.6% | ||
| 2022 | $3.11B | -186.4% | ||
| 2021 | -$3.60B | -255.3% | ||
| 2020 | $2.31B | +27.0% | ||
| 2019 | $1.82B | +23.8% | ||
| 2018 | $1.47B | -81.8% | ||
| 2017 | $8.11B | +80.7% | ||
| 2016 | $4.49B | +10.9% | ||
| 2015 | $4.05B | +32.4% | ||
| 2014 | $3.06B | +11.6% | ||
| 2013 | $2.74B | +0.7% | ||
| 2012 | $2.72B | +16.9% | ||
| 2011 | $2.33B | -7.8% | ||
| 2010 | $2.52B | +53.1% | ||
| 2009 | $1.65B | -16.3% | ||
| 2008 | $1.97B | +16.5% | ||
| 2007 | $1.69B | +10.7% | ||
| 2006 | $1.53B | +1151.6% | ||
| 2005 | $122.00M | -89.9% | ||
| 2004 | $1.21B | +29.9% | ||
| 2003 | $929.90M | +2.8% | ||
| 2002 | $905.00M | +101.0% | ||
| 2001 | $450.30M | +35.6% | ||
| 2000 | $332.10M | -37.5% | ||
| 1999 | $531.50M | +18.3% | ||
| 1998 | $449.40M | +173.0% | ||
| 1997 | $164.60M | -52.3% | ||
| 1996 | $345.40M | +589.4% | ||
| 1995 | $50.10M | — |
EBITDA values are taken from McKesson's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, McKesson (MCK) EBITDA totalled $5.25B – grew 12.5% year-over-year.
Over 2020–2025 (5 years), McKesson EBITDA expanded at a +17.8% compound annual rate, with the latest reading among the more recent periods of the dataset.
Between 2017 and 2025, McKesson EBITDA plunged 35.2%, falling from $8.11B to $5.25B.
$8.11B stands as the all-time-high annual EBITDA, posted in 2017, against a low of -$3.60B during 2021.
Within Healthcare, McKesson (MCK) ranks 9th among 8 peers we track. The peer median for EBITDA is $24.21B.
McKesson EBITDA by Year
McKesson EBITDA 2025: $5.25B
McKesson EBITDA in 2025 was $5.25B, grew 12.5% from 2024.
McKesson EBITDA 2024: $4.67B
McKesson EBITDA in 2024 was $4.67B, declined 18.6% below 2023.
McKesson EBITDA 2023: $5.74B
McKesson EBITDA in 2023 was $5.74B, surged 84.6% from 2022.
McKesson EBITDA 2022: $3.11B
McKesson EBITDA in 2022 was $3.11B, plunged 186.4% below 2021.
McKesson EBITDA 2021: -$3.60B
McKesson EBITDA in 2021 was -$3.60B.
See more financial history for McKesson (MCK).
Sector peers — EBITDA
Companies in the same sector as McKesson, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is McKesson's EBITDA?
- Latest reported EBITDA for McKesson (MCK) is $6.47B (period ending December 31, 2025).
How has McKesson EBITDA changed year-over-year?
- McKesson (MCK) EBITDA changed +12.5% year-over-year on the latest annual filing.
What is the long-term growth rate of McKesson EBITDA?
- McKesson (MCK) EBITDA compound annual growth rate is +17.8% over the most recent 5 years available.
When did McKesson EBITDA hit its highest annual value?
- McKesson EBITDA reached its highest annual value of $8.11B in 2017.
What was McKesson EBITDA in 2024?
- McKesson (MCK) EBITDA in 2024 was $4.67B.
What was McKesson EBITDA in 2025?
- McKesson (MCK) EBITDA in 2025 was $5.25B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
MCK Overview
Company profile, financial tools, and key metrics
MCK Revenue Counter
Earns $12,619 every second. See per minute, hour, and day.
MCK Earnings Counter
Earns $137.62 per second net profit. See per minute, hour, and day.
MCK Economic Scale
Exceeds Egypt, Arab Rep.'s GDP. Compare with world economies.
MCK What If Invested
What if you had invested $1,000? See historical returns from any date.
MCK How It Makes Money
Discover visual breakdown of $397.96B in revenue — where it comes from and where it goes.
MCK Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MCK Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MCK Daily Price Character
Steady · 51.5% historical win rate (green days). Streaks & record days.
MCK Buybacks
2.12% TTM buyback yield. Shareholder yield & SBC comparison.
MCK Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.
MCK Dividend Profile
Yield: 0.39%. Safety: 8/8. See full history.
MCK Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
MCK Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.